|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 31/436 | |
| A61K 31/4745 | |||
| A61K 31/5377 | |||
| A61K 31/52 | |||
| A61K 31/496 | |||
| A61K 45/06 | |||
| A61P 25/00 |
| (11) | Number of the document | 2675450 |
| (13) | Kind of document | T |
| (96) | European patent application number | 12705457.5 |
| Date of filing the European patent application | 2012-02-14 | |
| (97) | Date of publication of the European application | 2013-12-25 |
| (45) | Date of publication and mention of the grant of the patent | 2016-02-10 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/IB2012/050669 |
| Date | 2012-02-14 |
| (87) | Number | WO 2012/110953 |
| Date | 2012-08-23 |
| (30) | Number | Date | Country code |
| 201161443493 P | 2011-02-16 | US |
| (72) |
GALIMBERTI, Ivan, CH
MURPHY, Leon, US
|
| (73) |
Novartis AG,
Lichtstrasse 35, 4056 Basel,
CH
|
| (54) | COMBINATIONS OF THERAPEUTIC AGENTS FOR USE IN THE TREATMENT OF NEURODEGENERATIVE DISEASES |
| COMBINATIONS OF THERAPEUTIC AGENTS FOR USE IN THE TREATMENT OF NEURODEGENERATIVE DISEASES |